Michael Weiss

9PUBLICATIONS
19CO-AUTHORS
Characterisation of biological macromoleculesNeurology and neuromuscular diseasesPharmacology and pharmaceutical sciences not elsewhere classifiedMicroelectromechanical systems (MEMS)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 12, 2025
Amyotrophic Lateral Sclerosis, the Endocannabinoid System, and Exogenous Cannabinoids: Current State and Clinical Implications.

Travis T Denton, Gregory T Carter, Megan Goddard

|Nov 08, 2024
A 40-week phase 2B randomized, multicenter, double-blind, placebo-controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosis.

Salman Bhai, Todd Levine, Dan Moore

|Jul 10, 2024
Real world experience with sodium phenylbutyrate-taurursodiol for ALS: Lessons learned from a failed drug.

Nicholas Olney, Michael D Weiss

|Feb 24, 2024
Improvement of fatigue in generalised myasthenia gravis with zilucoplan.

Michael D Weiss, Miriam Freimer, M Isabel Leite

|Aug 29, 2023
Therapeutic targeting of ALS pathways: Refocusing an incomplete picture.

Nicholas J Maragakis, Mamede de Carvalho, Michael D Weiss

|Mar 29, 2023
Novel Variants in the <i>VCP</i> Gene Causing Multisystem Proteinopathy 1.

Rod Carlo Agram Columbres, Yue Chin, Sanjana Pratti

Pageof 2

Frequent Collaborators

2 joint publications

Zachary Simmons

1 joint publications

Stephen A Goutman

1 joint publications

Seward B Rutkove

1 joint publications

David Lacomis